Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimating behavioral multipliers to American black duck and lesser scaup resting metabolic rate to better estimate daily energy expenditure.

Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology·2026
Same author

GPIHBP1 on oligodendrocytes binds lipoprotein lipase within the human brain.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Interacting effects of human presence and landscape modification on birds and mammals.

Science (New York, N.Y.)·2026
Same author

Investigation of the myelin-amyloid interplay in Alzheimer's disease: insights from novel dsCMA imaging in mouse and human brains.

Acta neuropathologica communications·2026
Same author

Waterfowl Move Less in Heterogeneous and Human-Populated Landscapes, With Implications for Spread of Avian Influenza Viruses.

Ecology letters·2026
Same author

Foundational principles of an applied cultural evolutionary science for natural resource management and conservation.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2026

Related Experiment Video

Updated: Dec 28, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.0K

Enhanced Delivery of Rituximab Into Brain and Lymph Nodes Using Timed-Release Nanocapsules in Non-Human Primates.

Meng Qin1,2, Lan Wang1,2, Di Wu3

  • 1Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, United States.

Frontiers in Immunology
|February 13, 2020
PubMed
Summary

Encapsulated therapeutic monoclonal antibodies (mAbs) show improved delivery to the central nervous system (CNS) and lymph nodes (LNs). This nanocapsule technology enhances anti-tumor efficacy and is safe for clinical translation in treating metastatic cancers.

Keywords:
LNs deliverycentral nervous system deliverymonoclonal antibodynanocapsulesnon-human primate

More Related Videos

Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery
08:22

Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery

Published on: July 18, 2019

9.0K
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
18:46

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

13.6K

Related Experiment Videos

Last Updated: Dec 28, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.0K
Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery
08:22

Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery

Published on: July 18, 2019

9.0K
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
18:46

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

13.6K

Area of Science:

  • Nanotechnology
  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Tumor metastasis to the central nervous system (CNS) and lymph nodes (LNs) presents a significant challenge for cancer therapies.
  • Therapeutic monoclonal antibodies (mAbs) are effective against many cancers but show poor penetration into the CNS and LNs.
  • Inefficient mAb delivery to these metastatic sites limits their therapeutic efficacy.

Purpose of the Study:

  • To evaluate the enhanced delivery and therapeutic potential of encapsulated anti-CD20 mAb rituximab (n-RTX) in immunocompetent animal models.
  • To assess the safety and efficacy of n-RTX for treating CNS and LN metastases.
  • To explore the universal applicability of the nanocapsule platform for other therapeutic mAbs.

Main Methods:

  • Encapsulation of anti-CD20 mAb rituximab (RTX) into a polymer shell containing choline and acetylcholine receptor analogs to create n-RTX.
  • Administration of n-RTX and native RTX intravenously in xenografted humanized mice, rats, and non-human primates (NHPs).
  • Analysis of RTX levels in CNS and LNs, B-cell depletion in lymphoid organs, and hematological/liver enzyme activity tests in NHPs.

Main Results:

  • n-RTX demonstrated superior elimination of lymphoma cells and anti-tumor effects on CNS metastases compared to native RTX in mice.
  • Intravenous injection of n-RTX resulted in significantly higher RTX concentrations in the CNS (10-fold) and LNs (2-3-fold) in rats and NHPs.
  • n-RTX showed enhanced B-cell depletion in NHPs and was found to be safe based on hematological and liver enzyme analyses.

Conclusions:

  • The nanocapsule platform effectively enhances the delivery of therapeutic mAbs to the CNS and LNs.
  • n-RTX exhibits improved anti-tumor efficacy and a favorable safety profile in preclinical models, including NHPs.
  • This technology holds promise for extending mAb therapy to metastatic cancers in poorly accessible body compartments.